(Press-News.org) PHILADELPHIA — Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.
Data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Conference, held here Nov. 7-10, 2010, showed that women assigned to take aromatase inhibitors had increases in side effects such as hot flashes, decreased appetite, fatigue, fever, breast sensitivity, etc.
"Aromastase inhibitors represent one of the most major advances in breast cancer treatment," said Lisa Gallicchio, Ph.D., an epidemiologist at The Prevention and Research Center at Mercy Medical Center, Baltimore. "Their incorporation into the breast cancer treatment armamentarium has led to impressive reductions in breast cancer recurrence and mortality rates.
"Despite this, many breast cancer patients stop taking their aromatase inhibitor treatment —which is usually prescribed for five years — or do not adhere to their treatment prescription," she said, adding that this may be due to, at least in part, the side effects associated with the drugs.
To better define the full spectrum of side effects associated with aromatase inhibitor treatment, Gallicchio and colleagues surveyed 100 women with breast cancer who were about to start treatment with aromatase inhibitors. Their side effects were compared with those of 200 similarly-aged women without a history of breast cancer.
Questionnaires about symptoms were completed prior to treatment initiation by women with breast cancer and at the start of the study for the healthy women. Women were followed for six months and completed additional questionnaires at three months and at the completion of the study.
Women taking aromatase inhibitors were five times more likely to report having hot flashes, breast sensitivity and chest pain than healthy women. In addition, they were four times more likely to report night sweats, cold sweats and hair loss and about three times more likely to report leg cramps, weight gain, sleep disturbance, tendency to take naps and forgetfulness. Other increased symptoms included intestinal gas, cough, depression, interrupted sleep and irritability.
"We know that aromatase inhibitors are effective in treating breast cancer," Gallicchio said. "Knowing the side effects of aromatase inhibitor treatment and how to treat them is critical for keeping women on their aromatase inhibitor treatment and improving their chances of surviving and living cancer free."
###
Download interviews with cancer researchers and recordings of teleconferences by subscribing to the AACR Scientific Podcasts via iTunes (http://www.aacr.org/itunes) or an RSS Reader (http://www.aacr.org/rss).
Follow the AACR on Twitter: @AACR #AACR
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
2010-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Exercise may reduce risk of endometrial cancer
2010-11-10
PHILADELPHIA — Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
"This study is consistent with other studies that strongly support the association between physical activity and lower risk of endometrial cancer," said Hannah Arem, a doctoral student at Yale School of Public Health.
Arem and colleagues examined data collected from a case-control study ...
Long-term statin use is unlikely to increase cancer risk
2010-11-10
PHILADELPHIA — Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.
Statins are a class of drugs commonly used in the United States to lower cholesterol and reduce the risk of cardiovascular disease. While study results to date have shown that short-term use of statins has little effect on risk of developing cancer, not much is known ...
Very few eligible young women opt to take HPV vaccine
2010-11-10
PHILADELPHIA — Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10. What's more, many of the teens who begin treatment do not complete the recommended three-dose regimen.
"Only about one-third of young women who begin the three-dose series actually complete it; this means that large numbers of teenagers are unprotected or under-protected from strains of HPV that ...
Obesity in adolescence significantly associated with increased risk of severe obesity in adulthood
2010-11-10
An analysis of nationally representative data suggests that being obese in adolescence increases the risk of being severely obese in adulthood, with the risk higher in women, and highest for black women, according to a study in the November 10 issue of JAMA.
Individuals with severe obesity (body mass index [BMI] 40 or greater) encounter serious and potentially life-threatening health complications. "In 2000, an estimated 2.2 percent of adults, or 4.8 million individuals, were severely obese, with a disproportionately higher prevalence in women and racial/ethnic minorities. ...
Computer-automated monitoring system may help identify medical devices with potential safety risks
2010-11-10
Implementation in Massachusetts of a computer-automated safety surveillance system of clinical outcomes registries for cardiovascular devices resulted in the identification of a drug-releasing stent that had significantly higher rates of major adverse cardiac events than similar stents, according to a study in the November 10 issue of JAMA. The findings indicate that this type of system appears feasible and useful in identifying new cardiovascular devices with early low-frequency potential safety issues that are not observed in premarket approval studies.
"Monitoring ...
Variation in heart disease death risk in England largely attributed to population characteristics
2010-11-10
In England, a country with a universal access health care system, there is wide variation between local populations in the rate of death from coronary heart disease, which is largely explained by population characteristics such as low socioeconomic factors, white ethnicity, levels of smoking, and diabetes, according to a study in the November 10 issue of JAMA.
"Although mortality from coronary heart disease (CHD) has been steadily decreasing since the 1970s, it is still responsible for 15 percent of all deaths and nearly half of all circulatory disease deaths in England. ...
Significant variations found among medical centers regarding bloodstream infections surveillance
2010-11-10
The quality of public reporting of bloodstream infection rates among hospitals may be effected by the variation in surveillance methods, according to a study in the November 10 issue of JAMA.
"Public reporting of hospital-specific infection rates is widely promoted as a means to improve patient safety. Central line [central venous catheter]-associated bloodstream infection (BSI) rates are considered a key patient safety measure because such infections are frequent, lead to poor patient outcomes, are costly to the medical system, and are preventable. Publishing infection ...
BGI researchers sequenced the human methylome at single base-pair resolution
2010-11-10
DNA methylation plays an important role in many processes such as animal development, X-chromosome inactivation, and carcinogenesis. Understanding the mechanisms and functions of DNA methylation and how it varies from tissue to tissue and between individuals will have profound implications for human health and disease. A team of Chinese researchers decoded the essentially complete methylome (an inventory of all the bases that are methylated) of the human genome using peripheral blood mononuclear cells (PBMCs). The results will be published in the online, open access journal ...
Probiotics shorten diarrhea episodes
2010-11-10
Probiotic bacteria given as therapies for diarrhoea reduce the length of time sufferers are affected and lessen the chance of episodes continuing for more than four days. These are the findings of a new systematic review by Cochrane researchers.
Every year, diarrhoeal diseases kill nearly two million people in developing countries, mostly young children. The main treatment is rehydration fluids, but these do not tend to reduce the length of illness, which is crucial in reducing the risk of persistent diarrhoea. Probiotics, so-called "good bacteria", may help in a variety ...
Changing family behavior helps schizophrenic patients avoid relapse
2010-11-10
Working to change the behaviour of family members may be an effective treatment for people with schizophrenia, according to a new Cochrane systematic review. The researchers reviewed the most up-to-date evidence on the subject and found that patients whose families received the interventions were less likely to relapse.
It has long been known that people who have schizophrenia are more likely to relapse if they come from families where they experience high levels of criticism, hostility and over involvement. New psychosocial interventions that aim to reduce levels of ...